
New funding will help Coquitlam-based firm accelerate expansion in North America
Source link

New funding will help Coquitlam-based firm accelerate expansion in North America
Source link
Initiated in January 2024, Phase 1 study is being conducted in four countries, and is expected to be completed by November 2026.2 The study assessed pharmacokinetics, efficacy, safety, and immunogenicity…
Populations are ageing rapidly across Western economies, shifting the composition of the workforce toward older workers and raising concerns about long-run losses in growth and productivity (Aksoy et al. 2019,…
